175 related articles for article (PubMed ID: 15254145)
1. Inhibition of O6-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors: comparison with nonconjugated inhibitors and effect on fotemustine and temozolomide-induced cell death.
Kaina B; Mühlhausen U; Piee-Staffa A; Christmann M; Garcia Boy R; Rösch F; Schirrmacher R
J Pharmacol Exp Ther; 2004 Nov; 311(2):585-93. PubMed ID: 15254145
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.
Mühlhausen U; Schirrmacher R; Piel M; Lecher B; Briegert M; Piee-Staffa A; Kaina B; Rösch F
J Med Chem; 2006 Jan; 49(1):263-72. PubMed ID: 16392811
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of O(6)-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors.
Reinhard J; Eichhorn U; Wiessler M; Kaina B
Int J Cancer; 2001 Aug; 93(3):373-9. PubMed ID: 11433402
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity, DNA damage, and apoptosis induced by new fotemustine analogs on human melanoma cells in relation to O6-methylguanine DNA-methyltransferase expression.
Passagne I; Evrard A; Winum JY; Depeille P; Cuq P; Montero JL; Cupissol D; Vian L
J Pharmacol Exp Ther; 2003 Nov; 307(2):816-23. PubMed ID: 12970393
[TBL] [Abstract][Full Text] [Related]
6. Multidrug Efflux Pumps Attenuate the Effect of MGMT Inhibitors.
Tomaszowski KH; Schirrmacher R; Kaina B
Mol Pharm; 2015 Nov; 12(11):3924-34. PubMed ID: 26379107
[TBL] [Abstract][Full Text] [Related]
7. O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
Bobola MS; Silber JR; Ellenbogen RG; Geyer JR; Blank A; Goff RD
Clin Cancer Res; 2005 Apr; 11(7):2747-55. PubMed ID: 15814657
[TBL] [Abstract][Full Text] [Related]
8. A single cycle of treatment with temozolomide, alone or combined with O(6)-benzylguanine, induces strong chemoresistance in melanoma cell clones in vitro: role of O(6)-methylguanine-DNA methyltransferase and the mismatch repair system.
Alvino E; Castiglia D; Caporali S; Pepponi R; Caporaso P; Lacal PM; Marra G; Fischer F; Zambruno G; Bonmassar E; Jiricny J; D'Atri S
Int J Oncol; 2006 Oct; 29(4):785-97. PubMed ID: 16964376
[TBL] [Abstract][Full Text] [Related]
9. Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT.
Christmann M; Pick M; Lage H; Schadendorf D; Kaina B
Int J Cancer; 2001 Apr; 92(1):123-9. PubMed ID: 11279615
[TBL] [Abstract][Full Text] [Related]
10. Monosaccharide-linked inhibitors of O(6)-methylguanine-DNA methyltransferase (MGMT): synthesis, molecular modeling, and structure-activity relationships.
Reinhard J; Hull WE; von der Lieth CW; Eichhorn U; Kliem HC; Kaina B; Wiessler M
J Med Chem; 2001 Nov; 44(24):4050-61. PubMed ID: 11708909
[TBL] [Abstract][Full Text] [Related]
11. O(6)-methylguanine DNA-methyltransferase (MGMT) overexpression in melanoma cells induces resistance to nitrosoureas and temozolomide but sensitizes to mitomycin C.
Passagne I; Evrard A; Depeille P; Cuq P; Cupissol D; Vian L
Toxicol Appl Pharmacol; 2006 Mar; 211(2):97-105. PubMed ID: 16039682
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents.
Cai S; Xu Y; Cooper RJ; Ferkowicz MJ; Hartwell JR; Pollok KE; Kelley MR
Cancer Res; 2005 Apr; 65(8):3319-27. PubMed ID: 15833865
[TBL] [Abstract][Full Text] [Related]
13. O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro.
Turriziani M; Caporaso P; Bonmassar L; Buccisano F; Amadori S; Venditti A; Cantonetti M; D'Atri S; Bonmassar E
Pharmacol Res; 2006 Apr; 53(4):317-23. PubMed ID: 16412662
[TBL] [Abstract][Full Text] [Related]
14. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Aghi M; Rabkin S; Martuza RL
J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
[TBL] [Abstract][Full Text] [Related]
15. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
Fukuchi M; Mineura K; Kowada M; Terashima I; Kohda K
No To Shinkei; 1997 Jun; 49(6):521-8. PubMed ID: 9198092
[TBL] [Abstract][Full Text] [Related]
16. Targeting methylguanine-DNA methyltransferase in the treatment of neuroblastoma.
Wagner LM; McLendon RE; Yoon KJ; Weiss BD; Billups CA; Danks MK
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5418-25. PubMed ID: 17875772
[TBL] [Abstract][Full Text] [Related]
17. Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin.
Bobola MS; Tseng SH; Blank A; Berger MS; Silber JR
Clin Cancer Res; 1996 Apr; 2(4):735-41. PubMed ID: 9816224
[TBL] [Abstract][Full Text] [Related]
18. Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines.
Murakami J; Lee YJ; Kokeguchi S; Tsujigiwa H; Asaumi J; Nagatsuka H; Fukui K; Kuroda M; Tanaka N; Matsubara N
Oncol Rep; 2007 Jun; 17(6):1461-7. PubMed ID: 17487405
[TBL] [Abstract][Full Text] [Related]
19. Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanine.
Griffin RJ; Arris CE; Bleasdale C; Boyle FT; Calvert AH; Curtin NJ; Dalby C; Kanugula S; Lembicz NK; Newell DR; Pegg AE; Golding BT
J Med Chem; 2000 Nov; 43(22):4071-83. PubMed ID: 11063604
[TBL] [Abstract][Full Text] [Related]
20. The specific role of O
Sun G; Zhao L; Zhong R; Peng Y
Future Med Chem; 2018 Aug; 10(16):1971-1996. PubMed ID: 30001630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
